Galectin-3 Test Helps Assess Heart Failure Patients

Galectin-3 is a mediator of cardiac fibrosis (pictured) and adverse remodeling in heart failure patients.

A galectin-3 test helps assess the prognosis of patients with chronic heart failure. It is offered by Health Diagnostic Laboratory (HDL), using the BG Medicine Galectin-3 Test.

Elevated galectin-3 levels are associated with an inherently progressive form of heart failure that is associated with an increased risk of hospitalization or death. Galectin-3 has been implicated in a variety of biological processes important in heart failure development and progression, including fibrosis. Progressive cardiac fibrosis interferes with the cardiac pump function and increases the risk of death.